Do big Pharma need to re-address their key competencies?
-
Upload
christopher-watt -
Category
Business
-
view
181 -
download
0
Transcript of Do big Pharma need to re-address their key competencies?
Do big Pharma need to re-address their key
competencies? Professor Luigi
Martini
Patrick Crowley
Steve Wicks
Kurt Hertogs
Alex Robertson
13.35 – 14.35
Current Situation Recent news of Merck shedding a further 8,000 jobs, AZ relocation to Cambridge, Abbott
demerging and Pfizer perhaps demerging into separate business units
– Is the monolithic big pharma organisa2on which single handily discovers, develops, manufactures and markets new drug products under one roof now gone?
In 2007, a US 'think tank' discussed the Seven Key Skill Sets needed for the Pharmaceutical Industry, as follows: – Ability to manage decentralised intellectual capital resources – Ability to work in Joint Ventures and across divisions, cultures and countries
– Ability to integrate an understanding of IP laws, scien2fic exper2se and strategy
– Ability to spur crea2vity while managing commercially – Knowledge and insight on decision making dynamics of payers – Exper2se in func2on and decision making of regulatory agencies – HR skills to help transform pharmaceu2cal companies